|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Deferred offering costs | |||||||
| Current assets | |||||||
| Cash and cash equivalents | |||||||
| Prepaid expenses | |||||||
| Due from Sponsor | |||||||
| Total current assets | |||||||
| Long-term assets | |||||||
| Marketable securities held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | |||||||
| Current liabilities | |||||||
| Accrued expenses | |||||||
| Accrued offering costs | |||||||
| Total current liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| TOTAL LIABILITIES | |||||||
| Class A ordinary shares subject to possible redemption; $0.0001 par value; 25,300,000 shares at $10.06 and $10.00 per share redemption value as of September 30, 2022 and December 31, 2021 | |||||||
| Shareholders’ Deficit | |||||||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 756,000 shares issued and outstanding (excluding 25,300,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021 | |||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,325,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021 | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Shareholders’ Deficit | |||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...